BackNewAmsterdam Pharma Company NV Overview

NewAmsterdam Pharma Company NV Net Tangible Assets

Track NewAmsterdam Pharma Company NV's net tangible assets ($630M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$631.42M
↓ 18.89% YoYΔ $-147.07M vs prior year quarter

Peer average / median

Loading

NewAmsterdam Pharma Company NV Net Tangible Assets History

Loading

NewAmsterdam Pharma Company NV vs. peers: Net Tangible Assets Comparison

Loading

NewAmsterdam Pharma Company NV Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NewAmsterdam Pharma Company NV (NAMS) FAQ

As of the most recent data (June 2026), NAMS shows a net tangible assets of $630M. That compares with $780M in the prior-year period — down 18.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NAMS's net tangible assets is now $630M (was $780M) — a 18.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NewAmsterdam Pharma Company NV is outperforming or lagging.

Tracking NAMS's net tangible assets over time shows whether NewAmsterdam Pharma Company NV is scaling, shrinking, or reshaping that part of the business. The current reading is $630M That compares with $780M in the prior-year period — down 18.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has NewAmsterdam Pharma Company NV's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $630M) with ownership activity and broader fundamentals.